The leading microbiome company in oncology

We are a clinical-stage microbiome therapeutics company
aiming to improve survival in cancer.

Our strengths

A full ecosystem approach

Oncology focused

AI-Powered Drug Development

cGMP Versatile Manufacturing Capacities

Latest News

November 5, 2024

November 5, 2024: MaaT Pharma Provides Third Quarter 2024 Business and Financial Results and Announces Management Changes

October 29, 2024

October 25, 2024: Le Journal des biotechs : Hervé Affagard, MaaT Pharma (French only)

October 15, 2024

October 15, 2024: MaaT Pharma Completes Recruitment of its ARES Phase 3 Trial for MaaT013 to Treat Acute Graft-versus-Host Disease

Like what you see? See more posts

Our upcoming events

Event
October 3, 2024

Portzamparc’s Biotech and Life Sciences Conference

• October 8-9, 2024 – Portzamparc's Biotech and Life Sciences Conference
MaaT Pharma
Event
October 3, 2024

Investor Access Event

• October 15-16, 2024 – Investor Access Event
MaaT Pharma
Event
October 3, 2024

Annual congress of the SEHH and SETH

• October 24-26, 2024 – Annual congress of the SEHH and SETH
MaaT Pharma

Join the MaaT Pharma adventure!

Bring your talents, your passion and join an inclusive, creative, and multidisciplinary team. We aim to leverage the potential of microbiome to improve the treatment of patients with cancer.

Learn more about our values, our environment and see what we have to offer to you!

Careers